The store will not work correctly when cookies are disabled.
US9062043, Table 15, Compound 9::US9062043, Table 20, Compound 1
ID: ALA3700564
PubChem CID: 57664077
Max Phase: Preclinical
Molecular Formula: C17H10FN3O2S
Molecular Weight: 339.35
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)c1ccc2c(c1)nc(Nc1cccc(F)c1)c1ncsc12
Standard InChI: InChI=1S/C17H10FN3O2S/c18-10-2-1-3-11(7-10)20-16-14-15(24-8-19-14)12-5-4-9(17(22)23)6-13(12)21-16/h1-8H,(H,20,21)(H,22,23)
Standard InChI Key: LWIGZYQZGDSMIX-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1953 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1932 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4896 -3.7585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4844 -5.2585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1828 -6.0040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8863 -5.2495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8450 -5.8459 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.8915 -3.7495 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0114 1.7529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.4013 3.1233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.9095 2.9665 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 1 0
17 19 2 0
19 13 1 0
11 20 1 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 1 0
24 7 1 0
24 20 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 339.35 | Molecular Weight (Monoisotopic): 339.0478 | AlogP: 4.43 | #Rotatable Bonds: 3 |
Polar Surface Area: 75.11 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.62 | CX Basic pKa: ┄ | CX LogP: 4.11 | CX LogD: 0.77 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.42 |
References
1. (2015) Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators, |